how does semaglutide reduce cardiovascular risk in Cardiometabolic Diseases: SELECTing the Target Population SELECT Trial

Duro-Castano A, England RM, Razola D, Romero E, Oteo-Vives M, Morcillo MA, et al

4esthetics Lounge is ideal for those seeking personalized care that accounts for body composition, metabolic health, and overall wellness goals

Resources & Further Reading Nutrients Journal The Metabolic and Endocrine Effects of a 12-Week Allulose-Rich Diet BMJ Open Diabetes Research & Care Effects of D-Allulose on Glucose Tolerance PubMed Intestinal Distension Induced by Luminal D-Allulose Promotes GLP-1 Secretion

Nancy McGovern is our point person for all municipal health insurance activity

therefore, near-normal mean random glucose with SGLT2 inhibition has been reported in STZ-related rodent models (54)

Growing pressure on employer-sponsored plans, combined with mounting evidence of cardiovascular benefits, is slowly moving the needle